pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
PUBLIC COMPANY
save

$AZNASTRAZENECA PLC

$AZN164.95+3.03%
Cambridge, GBupdated 5h ago

AstraZeneca plc (AZ) is a Swedish–British multinational pharmaceutical and biotechnology company with its headquarters at the Cambridge Biomedical Campus in Cambridge, UK. It has a portfolio of products for major diseases in areas including oncology, cardiovascular, gastrointestinal, infection, neuroscience, respiratory, and inflammation.

SEC EDGAR ↗Yahoo Finance ↗
community read0 votes

🐶 often sniffed alongside

top 8
  • tagOncology15 co-mentions · 4 sources
  • tagNephrology3 co-mentions · 1 sources
  • tagNeurology3 co-mentions · 1 sources
  • tagPsychiatry & CNS3 co-mentions · 1 sources
  • tagBreast Cancer2 co-mentions · 1 sources
  • tagCOPD2 co-mentions · 1 sources
  • tagAdCom2 co-mentions · 2 sources
  • tagPulmonology2 co-mentions · 1 sources
pipeline
38
marketed
5
phase 3
7
catalysts ytd
12
approvals ytd
4
recalls ytd
0

Pipeline(38)

view full pipeline →
pipeline depth38 products
Preclinical: 1Phase 1: 1Phase 2: 14Phase 3: 7Marketed: 5pre_registration: 5Unknown: 5
1Preclinical1Phase 114Phase 27Phase 35Marketed5pre_registration5Unknown
Marketed
CALQUENCE
Tyrosine-protein kinase BTK
Marketed
capivasertib
Human Epidermal Growth Factor Receptor 2 Negative Breast…
Serine/threonine-protein kinase AKT
Marketed
dapagliflozin propanediol
Myocardial Infarction
Sodium/glucose cotransporter 2
Marketed
eplontersen sodium
Familial Amyloid Cardiomyopathy
Transthyretin mRNA
Marketed
osimertinib mesylate
Non-Small Cell Lung Cancer
Epidermal growth factor receptor
Phase 3
(balcinrenone + dapagliflozin)
Congestive Heart Failure (Heart Failure)
Phase 3
AZD-1390
Recurrent Glioblastoma Multiforme (GBM)
Phase 3
anifrolumab
Idiopathic Inflammatory Myopathy (IIM)
Interferon alpha/beta receptor 1
Phase 3
cediranib maleate
Epithelial Ovarian Cancer
Phase 3
sonesitatug vedotin
Adenocarcinoma Of The Gastroesophageal Junction
Phase 3
tozorakimab
Acute Respiratory Failure
Phase 3
tremelimumab
Small-Cell Lung Cancer
Cytotoxic T-lymphocyte protein 4

📅 Upcoming

Oct 30, 2026
earnings
$AZN164.95+3.03%
in 2mo
ASTRAZENECA PLC earnings
ASTRAZENECA PLC
→

🕒 Recent(90d)

earnings (1)
Jul 27, 2026
earnings
$AZN164.95+3.03%
24d ago
ASTRAZENECA PLC earnings
ASTRAZENECA PLC
→
view all catalysts →
🐶 Hiring Signal
next earnings Oct 30, 2026
980 open roles at ASTRAZENECA PLC →

Where ASTRAZENECA PLC is staffing up — a leading indicator of pipeline and commercial priorities.

therapeutic areaOncology 126Respiratory 53Immunology & Inflammation 22Rare Disease 16Hematology 15Cardiovascular 12
departmentMedical Affairs 109Business Development & Sales 94R&D / Discovery 78Commercial 62Clinical 48IT & Engineering 47

News

no news has mentioned this company yet
identifiers
ticker
$AZN
SEC CIK
0000901832
country
GB
source
sec_tickers
top tags
Oncology17NSCLC6Pulmonology6Infectious Disease4Cardiology3
mentioned in
0news items
entity-linker matched
Data sources
SEC EDGAR · openFDA
last refreshed 4m ago
Found something off?
🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?